Ramón Salazar
Head of Medical Oncology at the Catalan Institute of Oncology (ICO), head of the Colorectal Cancer Research Group, Oncobell programme (IDIBELL) and associate professor of Medicine at the University of Barcelona
Does the press release accurately reflect the study?
“Yes”.
Is the study of good quality? Are the conclusions supported by robust data?
“Absolutely, yes. GLOBOCAN and IARC are the WHO’s leading institutions for cancer epidemiology”.
How does this work fit in with the existing evidence?
“It is in line with previous trends and should serve as a guide for global planning strategies on primary prevention to avoid these infections.”
Have the authors taken confounding factors into account? Are there any significant limitations to bear in mind?
“Some regions have registries with lower-quality data, as the authors acknowledge. I do not see any fundamental methodological problems or confounding factors.”
What are the implications for the real world?
“Above all, in developing countries or emerging economies, it is advisable to strengthen plans for universal free vaccination, education and other measures that facilitate prevention, such as affordable access to condoms.”